Bill Text: NY S05439 | 2023-2024 | General Assembly | Amended

---

Bill Title: Designates Xylazine as a schedule III depressant.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced) 2024-01-03 - REFERRED TO HEALTH [S05439 Detail]

Download: New_York-2023-S05439-Amended.html

---

                STATE OF NEW YORK
        ________________________________________________________________________

                                         5439--A

                               2023-2024 Regular Sessions

                    IN SENATE

                                      March 6, 2023
                                       ___________

        Introduced  by  Sen. SKOUFIS -- read twice and ordered printed, and when
          printed to be committed  to  the  Committee  on  Health  --  committee
          discharged, bill amended, ordered reprinted as amended and recommitted
          to said committee

        AN  ACT to amend the public health law, in relation to designating Xyla-
          zine as a schedule III depressant

          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:

     1    Section  1.  Subdivision  (c)  of  schedule III of section 3306 of the
     2  public health law is amended by adding a new paragraph  15  to  read  as
     3  follows:
     4    (15)   Xylazine  (N-(2,6-dimethylphenyl)-5,6-dihydro-4H-1,3 thiazin-2-
     5  amine), including its salts, isomers and salts of isomers  whenever  the
     6  existence of such salts, isomers and salts of isomers is possible within
     7  the specific chemical designation.
     8    §  2.  This  act shall take effect on the ninetieth day after it shall
     9  have become a law.





         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD09888-02-3